Acetylsalicylic acid Withdrawn Phase 3 Trials for Aspirin / Survival / Non-Small Cell Lung Carcinoma (NSCLC) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01058902The Effect Of Aspirin On Survival in Lung Cancer